Related Experiment Videos
Coronary heart disease and hypertension
1Hypertension Center, VA Medical Center, Long Beach, California 90822.
Insights
Hypertension management often fails to prevent coronary events because it overlooks underlying metabolic and vascular issues. A comprehensive approach targeting proliferation and risk factors is crucial for younger patients to prevent coronary artery disease.
Area of Science:
- Cardiology
- Hypertension Research
- Vascular Biology
Background:
- Hypertension frequently leads to coronary disease, a complication not fully mitigated by conventional antihypertensive treatments.
- Existing clinical trials show reduced stroke and heart failure but not expected coronary event reductions.
- Hypertension is a complex syndrome involving inherited metabolic and cardiovascular abnormalities, not just elevated blood pressure.
Purpose of the Study:
- To explain the limited efficacy of current hypertension treatments in preventing coronary events.
- To introduce the coronary hypothesis in hypertension, detailing its three core components.
- To differentiate therapeutic strategies for elderly versus younger patients with hypertension-related coronary disease.
Main Methods:
- Review and synthesis of existing clinical trial data and pathophysiological mechanisms.
- Elaboration of the 'coronary hypothesis in hypertension' framework.
- Analysis of contributing factors to atherosclerotic disease in hypertensive individuals.
Main Results:
- Conventional antihypertensive therapy inadequately addresses the multifaceted nature of coronary disease in hypertension.
- The coronary hypothesis identifies three key contributors: intrinsic vascular proliferative activity, concomitant risk factors, and hemodynamic instability.
- Hemodynamic management is effective for advanced vascular changes in the elderly, but younger patients require broader interventions.
Conclusions:
- Effective prevention of coronary events in hypertension necessitates a broader therapeutic strategy beyond blood pressure control.
- Targeting intrinsic vascular proliferation and associated risk factors is essential for younger hypertensive patients.
- A comprehensive approach is required to address the complex interplay of factors contributing to coronary artery disease in hypertension.
Abstract:
Coronary disease is a frequent outcome of hypertension. Although clinical trials with conventional antihypertensive agents have shown that the incidence of other complications of hypertension, such as stroke or congestive heart failure, is reduced as predicted, they have failed to show the expected reductions in coronary events. A partial explanation may lie in the fact that hypertension typically consists of a syndrome of inherited metabolic and cardiovascular abnormalities, and treatment that focuses primarily on blood pressure control without taking into account other factors that contribute to atherosclerotic disease can have only limited protective effects. The coronary hypothesis in hypertension extends this reasoning into three separate components. First is an intrinsic tendency to excessive proliferative and hypertrophic activity within vascular tissue, presumably reflecting growth-promoting activity stimulated by increased endocrine and local paracrine effects; next is the impact of the commonly encountered concomitant risk factors, including high blood pressure, that exaggerate and accelerate development of underlying atherosclerotic lesions; and finally hemodynamic factors, including increased variability and sustained elevations of blood pressure, that can destabilize vascular lesions and precipitate acute events. Treatment of these hemodynamic factors in elderly patients whose underlying vascular changes are already well advanced is likely to reduce vascular endpoints effectively, but a broader-based therapeutic approach is required for younger patients, in whom the ongoing proliferative and risk factor aspects of their potential coronary disease must also be targeted.